The Paris Tribunal de Grande Instance [Regional Court] recently issued a landmark decision in the pharmaceutical industry. Whith 13 million euros of provisional damages – a record amount for an interim measure – the order issued by Mrs Courboulay Vice-Président of the 3rd Chamber, is particulary severe on the generic manufacturer Teva.